TCM
NVCR icon

Teza Capital Management’s NovoCure NVCR Stock Holding History

Teza Capital Management’s Portfolio NVCR Stock Details NVCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-10,122
Closed -$180K – 222
2025
Q2 		$180K Sell
10,122
-986
-9% -$17.2K 0.13% 284
2025
Q1 		$198K Sell
11,108
-89,092
-89% -$2.02M 0.09% 371
2024
Q4 		$2.99M Buy
100,200
+85,312
+573% +$1.81M 0.45% 44
2024
Q3 		$233K Sell
14,888
-10,886
-42% -$197K 0.03% 523
2024
Q2 		$442K Sell
25,774
-446
-2% -$7.84K 0.05% 381
2024
Q1 		$410K Buy
26,220
+14,792
+129% +$218K 0.05% 380
2023
Q4 		$171K Sell
11,428
-407
-3% -$5.45K 0.03% 506
2023
Q3 		$191K Buy
+11,835
New +$341K 0.03% 539
2023
Q1 		– Sell
-3,609
Closed -$265K – 652
2022
Q4 		$265K Buy
+3,609
New +$272K 0.05% 476
2021
Q3 		– Sell
-992
Closed -$220K – 523
2021
Q2 		$220K Buy
+992
New +$193K 0.04% 510

Other funds holding NVCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
QCM
Quantinno Capital Management New York $59.9B AUM 28.07% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Teza Capital Management's NVCR Position: Q3 2025 in Review

Teza Capital Management sold out of NovoCure (NVCR) in Q3 2025, closing a stake of 10,122 shares — an estimated $180K sold.

Teza Capital Management first reported a position in NVCR in Q2 2021 and held it in 10 quarters. The position peaked at $2.99M in Q4 2024. 244 funds tracked by Wall St. Rank hold NVCR as of Q3 2025.

  • Teza Capital Management reported no remaining NovoCure position as of Q3 2025 after selling out during the quarter.
  • Teza Capital Management sold 10,122 NovoCure shares in Q3 2025, an estimated $180K.
  • Teza Capital Management first reported a position in NovoCure in Q2 2021 and held it in 10 quarters.
  • Teza Capital Management's NovoCure position peaked at $2.99M in Q4 2024.
  • 244 funds tracked by Wall St. Rank held NovoCure as of Q3 2025.

Based on Teza Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.